Semustine

This classification denotes a nitrosourea compound, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6YY7T1T567. European Medicines Agency schedules Semustine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10482MIG. Semustine generally arises in the molecular formula C10H18CLN3O2. The term SEMUSTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, volume 26, no. 10 1972, list 12.) SEMUSTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, SEMUSTINE remains US FDA's Preferred Term for this commodity. Semustine bears US NLM identifiers UMLS ID C0036637 and NCI Concept Code C827. Most nations, for tariff and trade purposes, schedule semustine under HS 29242100 and SITC 51473. SMILES: CC1CCC(CC1)NC(=O)N(CCCl)N=O.